ArticlePharmaceuticals (Basel, Switzerland)2025

Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in

Eyra Ortiz-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.